Surviving cancer is often not a patient’s most challenging battle

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

With advances in treatment and screening for earlier detection, oncologists have improved cancer survival rates dramatically. That is excellent news, but the surging number of survivors means it is increasingly important for providers to focus more diligently on what patients need to thrive after treatment.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Boris C. Pasche, MD, PhD
President and CEO, Karmanos Cancer Institute, Chair, Department of Oncology, Wayne State University School of Medicine
Table of Contents

YOU MAY BE INTERESTED IN

“I don’t know of a single grant that left my desk that was not approved and funded,” NCI Director Anthony G. Letai said on this episode of The Cancer Letter Podcast. https://open.spotify.com/episode/2PFYGwliBDYEbxBXFd9MtB?si=95DNBAy0QGSKBX31_uETEA This episode is available on Spotify, Apple Podcasts, and Youtube. Letai recapped his first year as NCI director in conversation with Paul Goldberg,...

A year ago, when he was sworn in as director of the National Cancer Institute, Anthony G. Letai set a goal: Reassure cancer researchers that the institute will keep a steady course aimed at finding treatments for cancer.
Boris C. Pasche, MD, PhD
President and CEO, Karmanos Cancer Institute, Chair, Department of Oncology, Wayne State University School of Medicine

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login